Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel P Trefny

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Nature Reviews. Drug Discovery|June 26, 2025
Metabolites as agents and targets for cancer immunotherapyMarcel P Trefny, Guido Kroemer, Laurence Zitvogel, et al.
Cancer Research|October 19, 2023
Unraveling T-cell Exhaustion: Genetic Screening Meets In Vitro ModelingDominic Schmid, Priska Auf der Maur, Marcel P Trefny, et al.
Science Translational Medicine|November 9, 2022
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironmentNicole Kirchhammer, Marcel P Trefny, Priska Auf der Maur, et al.
Journal of Visualized Experiments : Jove|January 19, 2026
Serial Killing Assay Using Longitudinal Impedance-Based Tumor Cell Viability Measurement - A Useful Method to Assess T Cell PerformanceTengis Tschaidse, Marcel P Trefny, Emanuele Carlini, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2020
PD-1<sup>+</sup> natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockadeMarcel P Trefny, Monika Kaiser, Michal A Stanczak, et al.
Nature|June 3, 2021
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancyAna Luísa Correia, Joao C Guimaraes, Priska Auf der Maur, et al.
Medcomm|May 13, 2026
Development of CAR NK Cell Lines Selectively Targeting Cancer Cells Expressing Membrane Hsp70Khouloud Hachani, Mina Yazdi, Charlotte Carcopino, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunityLaura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, et al.
Cell Reports|September 26, 2019
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor ResponsesAbhishek S Kashyap, Laura Fernandez-Rodriguez, Yun Zhao, et al.
Nature Immunology|February 19, 2020
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumorsHaiping Wang, Fabien Franco, Yao-Chen Tsui, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Nature Reviews. Drug Discovery|June 26, 2025
Metabolites as agents and targets for cancer immunotherapyMarcel P Trefny, Guido Kroemer, Laurence Zitvogel, et al.
Cancer Research|October 19, 2023
Unraveling T-cell Exhaustion: Genetic Screening Meets In Vitro ModelingDominic Schmid, Priska Auf der Maur, Marcel P Trefny, et al.
Science Translational Medicine|November 9, 2022
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironmentNicole Kirchhammer, Marcel P Trefny, Priska Auf der Maur, et al.
Journal of Visualized Experiments : Jove|January 19, 2026
Serial Killing Assay Using Longitudinal Impedance-Based Tumor Cell Viability Measurement - A Useful Method to Assess T Cell PerformanceTengis Tschaidse, Marcel P Trefny, Emanuele Carlini, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2020
PD-1<sup>+</sup> natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockadeMarcel P Trefny, Monika Kaiser, Michal A Stanczak, et al.
Nature|June 3, 2021
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancyAna Luísa Correia, Joao C Guimaraes, Priska Auf der Maur, et al.
Medcomm|May 13, 2026
Development of CAR NK Cell Lines Selectively Targeting Cancer Cells Expressing Membrane Hsp70Khouloud Hachani, Mina Yazdi, Charlotte Carcopino, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunityLaura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, et al.
Cell Reports|September 26, 2019
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor ResponsesAbhishek S Kashyap, Laura Fernandez-Rodriguez, Yun Zhao, et al.
Nature Immunology|February 19, 2020
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumorsHaiping Wang, Fabien Franco, Yao-Chen Tsui, et al.
Pageof 3